Kelly E McCann - David Geffen School of Medicine, University of California, Los Angeles

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Trilaciclib Combined with Sacituzumab Govitecan (SG) in Metastatic Triple-Negative Breast Cancer (mtnbc): Updated Phase 2 Safety and Efficacy Results

Lasika C. Seneviratne,Kathleen Kiernan Harnden,Sibel Blau,Michael A. Danso,David Berz, Delia Constanza Guaqueta, John F. Schwerkoske,Joyce O'Shaughnessy,Debra A. Patt,Aditya Bardia,Kelly Elizabeth McCann,Andrew Paul Beelen,Jingshan Zhang,John S. Yi,Sara A. Hurvitz, Mabel Alejandra Mardones

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Clinical Significance of Background Parenchymal Enhancement in Breast Cancer Risk Stratification

Wakana Murakami,Shabnam Mortazavi,Tiffany Yu,Nikhita Kathuria-Prakash,Ran Yan,Cheryce Fischer,Kelly E. McCann,Stephanie Lee-Felker, Sung

JOURNAL OF MAGNETIC RESONANCE IMAGINGno. 5 (2024): 1742-1757

引用0浏览0WOS引用

Abstract PO1-17-08: Post-approval treatment patterns and tolerability of neratinib in HER2+ early-stage breast cancer

Kelly McCann,Nadia Harbeck,Debu Tripathy, Arlene Chan,Jay Andersen,Joyce O'Shaughnessy,Gregory Vidal

Cancer Researchno. 9_Supplement (2024): PO1-17

引用0浏览0引用

Supplemental Material for Biochemical, Molecular, and Clinical Characterization of SDHA VUS from Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance

Amber E. Bannon,Jason Kent,Isaac Forquer,Ajia Town,Lillian R. Klug,Kelly McCann,Carol Beadling,Oliver Harismendy,Jason K. Sicklick, Christopher L. Corless,Ujwal Shinde,Michael C. Heinrich

openalex（2023）

引用0浏览0引用

Supplemental Table 2 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

Zev A. Wainberg,Arun S. Singh,Gottfried E. Konecny,Kelly McCann,J. Randolph Hecht,Jonathan W. Goldman,Bartosz Chmielowski,Richard S. Finn,Neil A. O’Brien,Erika von Euw, Megan M. Price,Diego Martinez,Lisa Yonemoto,Meghan Brennan,John A. Glaspy,Dennis J. Slamon

openalex（2023）

引用1浏览0引用

Supplemental Table 1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

Zev A. Wainberg,Arun S. Singh,Gottfried E. Konecny,Kelly E. McCann,J. Randolph Hecht,Jonathan Goldman,Bartosz Chmielowski,Richard S. Finn,Neil O'Brien,Erika Von Euw, Megan M. Price,Diego Martinez,Lisa Yonemoto,Meghan Brennan,John A. Glaspy,Dennis J. Slamon

crossref（2023）

引用0浏览0引用

CLO23-051: Real-World Use of Neratinib in Patients with HER2-Positive Early-Stage Breast Cancer Following Prior Ado-Trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade with Pertuzumab Plus Trastuzumab

Kelly E. McCann,Nina Oestreicher,Christopher G. Rowan,Gregory A. Vidal

Journal of the National Comprehensive Cancer Networkno. 3.5 (2023): CLO23-051

引用0浏览0引用

Updates in the Treatment of HR+HER2- Breast Cancer

Nikita V Baclig,Kelly E McCann

Current opinion in obstetrics & gynecologyno. 1 (2023): 57-63

引用0浏览0WOS引用

Video for Biochemical, Molecular, and Clinical Characterization of SDHA VUS from Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance

Amber E. Bannon,Jason Kent,Isaac Forquer,Ajia Town,Lillian R. Klug,Kelly McCann,Carol Beadling,Oliver Harismendy,Jason K. Sicklick, Christopher L. Corless,Ujwal Shinde,Michael C. Heinrich

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn